Cell-based medicinal products approved in the European Union: current evidence and perspectives

Advanced Therapy Medicinal Products (ATMPs) are innovative clinical treatments exploiting the pharmacological, immunological, or metabolic properties of cells and/or gene(s) with the aim to restore, correct, or modify a biological function in the recipient. ATMPs are heterogeneous medicinal products...

Descripción completa

Detalles Bibliográficos
Autores principales: Bellino, Stefania, La Salvia, Anna, Cometa, Maria Francesca, Botta, Rosanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424920/
https://www.ncbi.nlm.nih.gov/pubmed/37583902
http://dx.doi.org/10.3389/fphar.2023.1200808

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424920/
https://www.ncbi.nlm.nih.gov/pubmed/37583902
http://dx.doi.org/10.3389/fphar.2023.1200808

Ejemplares similares